Tianjin Pharmaceutical Da Ren Tang Group Announces Proposed Transfer of 100% Equity in Upstream Shareholder via Public Tender (2026)
Tianjin Pharmaceutical Da Ren Tang Group: Key Upstream Share...
Sign in to continue:
Tianjin Pharmaceutical Da Ren Tang Group: Key Upstream Share...
Aspial Lifestyle Limited Receives SGX-ST Approval In-Princip...
Ho Bee Land 2026 AGM: Key Highlights and Investor Implicatio...
Phancy Group Announces Strategic Partnership with Huanxi Med...
Kingsoft Cloud Holdings Sets Record Dates for 2026 Annual Ge...
Qingling Motors Repurchase Agreement - Detailed Investor Rep...
Duality Biotherapeutics Announces Share Repurchase Plan and ...
ImmuneOnco Biopharmaceuticals Announces First Patient Dosed ...
Strong Petrochemical Holdings Limited - Expected Loss in Tra...
Shanghai Top Numerical Control Technology Co., Ltd. - Detail...